Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bates

Showing results (381-390 of 430) with videos related to

Pageof 43
Sort By:
Journal of Proteome Research|June 8, 2007
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidatesAnnette Dalrymple, Edward J Wild, Richard Joubert, et al.
Plos Genetics|March 10, 2015
HDAC4-myogenin axis as an important marker of HD-related skeletal muscle atrophyMichal Mielcarek, Marta Toczek, Cleo J L M Smeets, et al.
Neurobiology of Disease|August 23, 2005
Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's diseaseEmma Hockly, Jamie Tse, Amy L Barker, et al.
The Journal of Clinical Investigation|September 22, 2012
Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progressionAndreas Weiss, Ulrike Träger, Edward J Wild, et al.
Brain Communications|February 9, 2023
Early detection of exon 1 huntingtin aggregation in zQ175 brains by molecular and histological approachesEdward J Smith, Kirupa Sathasivam, Christian Landles, et al.
Plos Currents|February 22, 2014
The PDE1/5 Inhibitor SCH-51866 Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's DiseaseVahri Beaumont, Larry Park, Arash Rassoulpour, et al.
Cell Reports|September 1, 2021
FAN1 controls mismatch repair complex assembly via MLH1 retention to stabilize CAG repeat expansion in Huntington's diseaseRobert Goold, Joseph Hamilton, Thomas Menneteau, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington diseaseKirupa Sathasivam, Andreas Neueder, Theresa A Gipson, et al.
Journal of Neuroscience Research|July 9, 2019
Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin geneNicholas R Franich, Miriam A Hickey, Chunni Zhu, et al.
The European Journal of Neuroscience|November 22, 2012
Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse modelsEric A Horne, Jonathan Coy, Katie Swinney, et al.
Pageof 43

Showing results (381-390 of 430) with videos related to

Sort By:
Pageof 43
Journal of Proteome Research|June 8, 2007
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidatesAnnette Dalrymple, Edward J Wild, Richard Joubert, et al.
Plos Genetics|March 10, 2015
HDAC4-myogenin axis as an important marker of HD-related skeletal muscle atrophyMichal Mielcarek, Marta Toczek, Cleo J L M Smeets, et al.
Neurobiology of Disease|August 23, 2005
Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington's diseaseEmma Hockly, Jamie Tse, Amy L Barker, et al.
The Journal of Clinical Investigation|September 22, 2012
Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progressionAndreas Weiss, Ulrike Träger, Edward J Wild, et al.
Brain Communications|February 9, 2023
Early detection of exon 1 huntingtin aggregation in zQ175 brains by molecular and histological approachesEdward J Smith, Kirupa Sathasivam, Christian Landles, et al.
Plos Currents|February 22, 2014
The PDE1/5 Inhibitor SCH-51866 Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's DiseaseVahri Beaumont, Larry Park, Arash Rassoulpour, et al.
Cell Reports|September 1, 2021
FAN1 controls mismatch repair complex assembly via MLH1 retention to stabilize CAG repeat expansion in Huntington's diseaseRobert Goold, Joseph Hamilton, Thomas Menneteau, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 24, 2013
Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington diseaseKirupa Sathasivam, Andreas Neueder, Theresa A Gipson, et al.
Journal of Neuroscience Research|July 9, 2019
Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin geneNicholas R Franich, Miriam A Hickey, Chunni Zhu, et al.
The European Journal of Neuroscience|November 22, 2012
Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse modelsEric A Horne, Jonathan Coy, Katie Swinney, et al.
Pageof 43